Kura Oncology Inc Dividends

The next dividend date for Kura Oncology Inc has not yet been scheduled.

What is a Dividend Date

When we talk about a dividend date, we’re referring specifically to the ex-dividend date.

This is the date on which all stockholders will earn a dividend. Technically, a person needs to be the owner of a share of stock as of the night before the ex-dividend date in order to earn the dividend.

The ex-dividend date is different than the date when the dividend is issued. Although you earn a dividend on the ex-dividend date, that dividend is typically not disbursed to your account until several weeks later.

Most brokerages will automatically credit the dividend to your account once it’s issued.

Historical Dividends for Kura Oncology Inc (KURA)

No Results.
DateDeclaration DateRecord DatePayment DateAmount
No Results.

More About Kura Oncology Inc

Country
USA
Full Time Employees
192

Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer. Its lead product candidate includes ziftomenib, a selective investigational inhibitor of the menin-KMT2A interaction for the treatment of genetically defined subsets of acute leukemias, including acute myeloid leukemia and acute lymphoblastic leukemia; tipifarnib, an orally bioavailable farnesyl transferase inhibitor combination with alpelisib for patients with PIK3CA-dependent HNSCC; and KO-2806, a selective investigational FTI for the treatment of solid tumors. It has a clinical collaboration with Novartis Pharma AG to evaluate the combination of tipifarnib and alpelisib in patients with head and neck squamous cell carcinoma whose tumors have HRAS overexpression and/or PIK3CA mutation and/or amplification; strategic collaboration agreement with Kyowa Kirin Co., Ltd. to develop and commercialize its oral menin inhibitor for the treatment of patients with acute myeloid leukemia (AML) and other hematologic malignancies; and a clinical collaboration with Mirati Therapeutics, Inc. to evaluate the combination of KO-2806 and adagrasib, a KRASG12C inhibitor in patients with NSCLC. The company is headquartered in San Diego, California.

Owning Kura Oncology Inc Stock on the Dividend Date

If you own Kura Oncology Inc stock on the ex-dividend date, then you earn the associated dividend.

Theoretically, the price of Kura Oncology Inc stock should go down by the amount of the dividend (in addition to any other pressures that market forces have on the price of Kura Oncology Inc stock).

Therefore, it is typically not expected that there is any incremental profit to be gained from buying Kura Oncology Inc stock right before the ex-dividend date and then selling it immediately after. It’s not like you get the Kura Oncology Inc dividend payout for free just by doing that since there is typically an equivalent commensurate drop in the stock price.

Learning More Kura Oncology Inc Dividends

You can contact us any time if you would like to ask questions about Kura Oncology Inc dividends or anything else related to the stock market.